all AI news
Genesis Therapeutics closes Oversubscribed $200 Million Series B
AI – AI-TechPark ai-techpark.com
Series B capital will be deployed to: Bring forward Genesis’ artificial intelligence-enabled pipeline into clinical development Further advance Genesis’ field-leading physics-based AI platform Ambitiously expand Genesis’ pipeline, targeting the company’s AI platform against new high-value and previously undrugged targets Series B raise brings Genesis’ total capital raised since inception to...
The post Genesis Therapeutics closes Oversubscribed 0 Million Series B first appeared on AI-TechPark.
advance ai ai platform artificial artificial intelligence capital development genesis intelligence physics pipeline platform series series b therapeutics total value